These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 29844263

  • 21. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
    Sun H, Zhang Y, Ding W, Zhao X, Song X, Wang D, Li Y, Han K, Yang Y, Ma Y, Wang R, Wang D, Yu P.
    Eur J Med Chem; 2016 Nov 10; 123():365-378. PubMed ID: 27487567
    [Abstract] [Full Text] [Related]

  • 22. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives.
    Hussain F, Khan Z, Jan MS, Ahmad S, Ahmad A, Rashid U, Ullah F, Ayaz M, Sadiq A.
    Bioorg Chem; 2019 Oct 10; 91():103128. PubMed ID: 31369977
    [Abstract] [Full Text] [Related]

  • 23. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
    Asgari MS, Mohammadi-Khanaposhtani M, Kiani M, Ranjbar PR, Zabihi E, Pourbagher R, Rahimi R, Faramarzi MA, Biglar M, Larijani B, Mahdavi M, Hamedifar H, Hajimiri MH.
    Bioorg Chem; 2019 Nov 10; 92():103206. PubMed ID: 31445191
    [Abstract] [Full Text] [Related]

  • 24. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.
    Al-Salahi R, Ahmad R, Anouar E, Iwana Nor Azman NI, Marzouk M, Abuelizz HA.
    Future Med Chem; 2018 Aug 01; 10(16):1889-1905. PubMed ID: 29882426
    [Abstract] [Full Text] [Related]

  • 25. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.
    Zawawi NK, Taha M, Ahmat N, Ismail NH, Wadood A, Rahim F, Rehman AU.
    Bioorg Chem; 2015 Dec 01; 63():36-44. PubMed ID: 26432614
    [Abstract] [Full Text] [Related]

  • 26. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
    Wang G, He D, Li X, Li J, Peng Z.
    Bioorg Chem; 2016 Apr 01; 65():167-74. PubMed ID: 26964016
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
    Wali S, Atia-Tul-Wahab, Ullah S, Khan MA, Hussain S, Shaikh M, Atta-Ur-Rahman, Choudhary MI.
    Bioorg Chem; 2022 Feb 01; 119():105506. PubMed ID: 34896920
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Indane-1,3-diones: As Potential and Selective α-glucosidase Inhibitors, their Synthesis, in vitro and in silico Studies.
    Mukhtar A, Shah S, Kanwal, Hameed S, Khan KM, Khan SU, Zaib S, Iqbal J, Perveen S.
    Med Chem; 2021 Feb 01; 17(8):887-902. PubMed ID: 32851965
    [Abstract] [Full Text] [Related]

  • 34. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
    Wang G, Peng Z, Wang J, Li J, Li X.
    Bioorg Med Chem; 2016 Nov 01; 24(21):5374-5379. PubMed ID: 27614916
    [Abstract] [Full Text] [Related]

  • 35. Exploration of aroyl/heteroaroyl iminothiazolines featuring 2,4,5-trichlorophenyl moiety as a new class of potent, selective, and in vitro efficacious glucosidase inhibitors.
    Kazmi M, Zaib S, Amjad ST, Khan I, Ibrar A, Saeed A, Iqbal J.
    Bioorg Chem; 2017 Oct 01; 74():134-144. PubMed ID: 28780150
    [Abstract] [Full Text] [Related]

  • 36. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
    Wang G, Wang J, He D, Li X, Li J, Peng Z.
    Chem Biol Drug Des; 2017 Mar 01; 89(3):456-463. PubMed ID: 27616456
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M, Mohammadi-Khanaposhtani M, Pourrabia P, Razzaghi N, Ghadimi R, Imanparast S, Faramarzi MA, Bandarian F, Esfahani EN, Safavi M, Rastegar H, Larijani B, Mahdavi M, Akbarzadeh T.
    Bioorg Chem; 2019 Mar 01; 83():161-169. PubMed ID: 30366316
    [Abstract] [Full Text] [Related]

  • 40. Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of α-glucosidase enzyme along with in silico study.
    Alomari M, Taha M, Rahim F, Selvaraj M, Iqbal N, Chigurupati S, Hussain S, Uddin N, Almandil NB, Nawaz M, Khalid Farooq R, Khan KM.
    Bioorg Chem; 2021 Mar 01; 108():104638. PubMed ID: 33508679
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.